Search Result "chemotherapy PARP inhibition"
Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Cancer Chemotherapy
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 1 Year: 2006 Page: 39-53
Author(s): Victoria Cepeda, Miguel A. Fuertes, Josefina Castilla, Carlos Alonso, Celia Quevedo, Manual Soto, Jose M. Perez
Targeted Therapy for Brain Tumours: Role of PARP Inhibitors
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 3 Year: 2012 Page: 218-236
Author(s): C. Leonetti, A. Biroccio, G. Graziani, L. Tentori
PARP Inhibitors in Epithelial Ovarian Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13 Issue: 2 Year: 2018 Page: 145-158
Author(s): Kristin N. Taylor,Ramez N. Eskander
Inducing Synthetic Lethality using PARP Inhibitors
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 3 Year: 2010 Page: 192-195
Author(s): David S. Boss, Jos H. Beijnen, Jan H.M. Schellens
PARP Inhibitors in Colorectal Malignancies: A 2023 Update
Journal: Reviews on Recent Clinical Trials
Volume: 19 Issue: 2 Year: 2024 Page: 101-108
Author(s):
Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 16 Issue: 2 Year: 2018 Page: 108-117
Author(s): Wei-Hua Shao,Lei-Yun Wang,Ji-Ye Yin
Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP Inhibitors
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 7 Year: 2010 Page: 520-533
Author(s): Anthony J. Chalmers
Pharmacological Effects of PARP Inhibitors on Cancer and other Diseases
Journal: Current Enzyme Inhibition
Volume: 7 Issue: 4 Year: 2011 Page: 244-258
Author(s): Luis M. Guaman-Ortiz, Vincenzo Giansanti, Francesca Dona, A. Ivana Scovassi
PARP Inhibitors in Ovarian Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13 Issue: 4 Year: 2018 Page: 392-410
Author(s): Gloria Mittica,Eleonora Ghisoni,Gaia Giannone,Sofia Genta,Massimo Aglietta,Anna Sapino,Giorgio Valabrega
Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 4 Year: 2010 Page: 368-383
Author(s): L. Tentori, A. Muzi, A.S. Dorio, M. Scarsella, C. Leonetti, G.M. Shah, W. Xu, E. Camaioni, B. Gold, R. Pellicciari, F. Dantzer, J. Zhang, G. Graziani